Report Code: A13939 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Endocrinology is the branch of medicine that deals with endocrine and metabolic disorders. Three different classes of hormones based on their chemical composition include amines, steroids, and peptides & proteins. The endocrine system is made of hormone-producing glands, such as the pancreas, thyroid, parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus. These hormones control metabolism, reproduction, growth, and development.
Doctors who are specially trained in treating hormone imbalances and disorders are known as endocrinologists. Most endocrine disorders are chronic and need constant treatment. Some commonly treated endocrine disorders are osteoporosis, diabetes mellitus, thyroid, and hyperparathyroid disorders. Some less common but serious endocrine disorders are Cushing’s syndrome, Addison’s disease, pheochromocytoma, and diseases of sexual development.
COVID-19 Impact analysis
Top Impacting Factors
Increase in the prevalence of endocrine hormone-related diseases propels the growth of the endocrinology drugs market.
The presence of robust product pipelines in the endocrinology drugs market for the treatment of both types of diabetes mellitus will boost the market growth.
Extensive research and development, initiation of new drug delivery systems, and rise in disposable income propel the growth of the endocrinology drugs market.
Rapid uptake of novel dosage forms and formulations of present drugs is expected to increase the number of patients for the treatment of endocrine disorders, thus augmenting market growth.
On the contrary, illegal use of certain drugs by sports professionals poses a danger to society, thereby deterring the growth of the endocrinology drugs market.
Rising number of cases of hypogonadism in men, provoked by diabetes, heart, or renal disorders is anticipated to create lucrative opportunities for market players.
Increasing awareness among people about diabetes, thyroid, and other hormone-related disorders is further expected to drive the market growth during the forecast period.
Surge in usage in endocrinology drugs
Key Benefits of the Report
Questions Answered in the Endocrinology Drugs Report
Endocrinology Drugs Market Report Highlights
Aspects | Details |
---|---|
By Therapy Area |
|
By End User |
|
By Region |
|
Key Market Players | Facet Biotech Corporation,, Novo Nordisk A/S,, Sanofi., Alacer Corporation,, Abbott Laboratories,, Eli Lilly and Company,, F. Hoffmann La Roche Ltd.,, Pfizer Inc.,, Novartis International AG, |
Loading Table Of Content...
Start reading.
This Report and over 71,323+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers